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Neutrophil elastase cleaves epithelial
cadherin in acutely injured lung epithelium
Rachel Boxio1, Julien Wartelle1, Béatrice Nawrocki-Raby2, Brice Lagrange1, Laurette Malleret1, Timothee Hirche3,
Clifford Taggart4, Yves Pacheco1, Gilles Devouassoux1,5 and Abderrazzaq Bentaher1*
Abstract
Background: In acutely injured lungs, massively recruited polymorphonuclear neutrophils (PMNs) secrete abnormally
neutrophil elastase (NE). Active NE creates a localized proteolytic environment where various host molecules
are degraded leading to impairment of tissue homeostasis. Among the hallmarks of neutrophil-rich pathologies is a
disrupted epithelium characterized by the loss of cell-cell adhesion and integrity. Epithelial-cadherin (E-cad) represents
one of the most important intercellular junction proteins. E-cad exhibits various functions including its role in
maintenance of tissue integrity. While much interest has focused on the expression and role of E-cad in different physio-
and physiopathological states, proteolytic degradation of this structural molecule and ensuing potential consequences on
host lung tissue injury are not completely understood.
Methods: NE capacity to cleave E-cad was determined in cell-free and lung epithelial cell culture systems. The impact of
such cleavage on epithelial monolayer integrity was then investigated. Using mice deficient in NE in a clinically relevant
experimental model of acute pneumonia, we examined whether degraded E-cad is associated with lung inflammation
and injury and whether NE contributes to E-cad cleavage. Finally, we checked for the presence of both degraded E-cad
and NE in bronchoalveolar lavage samples obtained from patients with exacerbated COPD, a clinical manifestation
characterised by a neutrophilic inflammatory response.
Results: We show that NE is capable of degrading E-cad in vitro and in cultured cells. NE-mediated degradation of E-cad
was accompanied with loss of epithelial monolayer integrity. Our in vivo findings provide evidence that NE contributes to
E-cad cleavage that is concomitant with lung inflammation and injury. Importantly, we observed that the presence of
degraded E-cad coincided with the detection of NE in diseased human lungs.
Conclusions: Active NE has the capacity to cleave E-cad and interfere with its cell-cell adhesion function. These data
suggest a mechanism by which unchecked NE participates potentially to the pathogenesis of neutrophil-rich lung
inflammatory and tissue-destructive diseases.
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Background
To protect itself against various infectious or toxic
agents, the lung relies on different mechanisms. Among
these latter, the epithelium and resident macrophages
are considered as the first lines of lung tissue protection.
With respect to the epithelium, this cell lining partici-
pates in mounting an appropriate inflammatory response
against insulting agents but acts primarily as a
physicochemical barrier for efficient defence [1]. Indeed,
various structural molecules are known to establish tight
epithelial cell-cell adhesion and along with their connec-
tion to the internal cytoskeleton provide the lung with
an intact and impermeable epithelium [2].
When these “sentinel” lines are breached, neutrophils
are called in. The primary purpose of this neutrophilic
infiltration is phagocytosis of foreign particles and/or
contribution to the resolution of associated inflamma-
tion [3]. To this end, two systems categorized as oxygen-
dependent and -independent have been described in
neutrophils [4]. The non-oxidative system comprises the
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readily active serine proteinase, neutrophil elastase (NE),
among other polypeptides. NE is structurally related to
its family members, cathepsin G and proteinase 3, and
share the conserved charge-relay triad, His57-Asp102-
Ser195, where Ser is the active residue (chymotrypsino-
gen numbering) [5]. NE, a potent proteolytic enzyme, is
stored in an active form at high concentration in pri-
mary granules (~4 μg/106 cells) making it a major com-
ponent of neutrophils [6]. The enzyme is rapidly
discharged into the phagolysosome following bacterial
uptake by neutrophils. Previously, we and others have
shown that NE is required for maximal neutrophil
killing of invading pathogens [7–10].
In the setting of overwhelming inflammatory condi-
tions, activated neutrophils secrete abnormally NE in the
extracellular space [11]. Active NE creates a localized
proteolytic environment where a wide range of host
soluble and insoluble molecules could be degraded. As a
consequence, NE has been incriminated in the patho-
genesis of different acute and chronic tissue-destructive
diseases including acute lung injury/acute respiratory
distress syndrome (ALI/ARDS), cystic fibrosis (CF) and
chronic obstructive pulmonary diseases (COPD) (e.g.,
emphysema) [12, 13]. Among the common hallmarks of
these pathologies is a disrupted epithelium characterized
by the loss of its integrity and sloughing of epithelial
cells [14]. The likelihood that NE is associated with these
diseased situations is supported by at least two lines of
evidence. First, NE is potent proteolytic enzyme with a
large substrate repertoire comprising extracellular
matrix proteins [15]. Second, various human and animal
studies reported the presence of free active NE in lung
tissues and fluids overwhelming the anti-NE screen
[16–20]. Whether NE has the capacity to alter the
tight epithelial cell-cell adhesion contributing to lung
tissue destruction is not completely addressed particu-
larly in vivo.
E-cad represents one of the most important and ubi-
quitous adherens junction protein. E-cad, a member of
the cadherin superfamily, is a glycoprotein that crosses
the membrane only once [21]. The extracellular portion
of E-cad consists of a domain of five repeats that are
highly homologous to each other and commonly desig-
nated as EC1-EC5 (EC1 being the beginning of E-cad
N-terminus). Each repeat is comprised of approximately
110 amino acid residues. This extracellular domain en-
sures homophilic recognition and Ca2 + −dependent
cell-cell adhesion. Intracellularly, E-cad cytoplasmic do-
main is linked to actin filaments through interactions
with catenin proteins reinforcing, as mentioned above,
the stability of the epithelium [22]. Other functions of
E-cad include its role as a signalling molecule and regu-
lator of the epithelium permeability and polarity [23].
The protein is implicated in a number of biological
processes including tissue/organ development, morpho-
genesis, and cytoskeletal organization [23]. Much inter-
est has focused on the expression and role of E-cad in
different physio- and physiopathological states. Limited
studies have, however, dealt with the proteolytic degrad-
ation of this structural molecule by NE and ensuing con-
sequences on host tissue architecture (e.g., contribution
to lung tissue injury). In a rat model of pancreatitis,
Mayerle J. et al. reported that neutrophil-derived NE,
rather than pancreatic elastase, degraded E-Cad [24].
Evans SM and his colleagues observed released E-cad
into the BAL fluids in a mouse model challenged with
human NE [25]. Work by Downey G. and his colleagues
identified a mechanism whereby NE-mediated cleavage
of E-cad induced β-catenin signalling, which appears to
play a critical role in reepithelialisation of denuded epi-
thelium in a mouse lung inflammation model [26]. The
ability of NE to degrade other cell-cell junction proteins
prior to E-cad may not be ruled out [27]. Of interest as
well, it has been reported that NE mediates degradation
of vascular E-cad (VE-cad) that could compromise the
endothelial vascular integrity contributing to micro-
vascular injury and increased permeability and intersti-
tial oedema [28].
The goals of these studies were several folds. We
sought to determine if NE could cleave E-cad and alter
its ability to maintain a stable lung epithelial cell mono-
layer. Next, using mice deficient in NE in a clinically
relevant experimental model of acute pneumonia, we
wanted to determine whether degraded E-cad is associ-
ated with lung inflammation and injury and whether NE
contributes to E-cad cleavage. Finally, in order to deter-
mine the potential relevance of our findings to human
lung diseases, we examined whether degraded E-cad coin-
cides with the presence of active NE in bronchoalveolar
lavage samples obtained from patients with exacerbated
COPD, a clinical condition characterized by a neutrophilic
inflammatory response.
Methods
Reagents
Purified human NE, CG and PR3 and NE corresponding
polyclonal rabbit antibody were from Elastin Products
Company (Owensville, MO, USA). The purity and activity
of each enzyme were confirmed by sodium-dodecyl-
sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
and spectrophotometrically using specific substrates
according to the manufacturer’s recommendations. The
chromogenic peptide substrates were N-methoxysuccinyl-
Al-Al-Pro-Val-pNA, N-Boc-Ala-ONp, and N-succinyl-Al-
Al-Pro-Phe-pNA for NE, PR3 and CG, respectively.
Chromogenic peptide substrates were obtained from
Elastin Products Company. Recombinant human secretory
leukocyte proteinase inhibitor (SLPI) and polyclonal rabbit
Boxio et al. Respiratory Research  (2016) 17:129 Page 2 of 15
antibody for mouse extracellular E-Cadherin domain were
from R&D Systems Europe. Monoclonal mouse antibodies
for human extracellular and polyclonal rabbit antibody
against human cytoplasmic E-Cadherin domain were from
Cell Signalling Technology (Ozyme) and Takara (Cambrex
Bio Science). Monoclonal mouse antibody against human
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was
from Chemicon International (Abcys). Secondary FITC-
labelled or HRP conjugated polyclonal goat antibody
against mouse immunoglobulin and secondary FITC-
labelled or HRP conjugated polyclonal swine antibody
against rabbit immunoglobulin were from Dakocytomation
(Trappe’s). All tissue culture reagents and other chemicals
were reagent grade and purchased from Invitrogen or
Sigma-Aldrich.
Human samples, mice, cells, and bacteria
Bronchoalveolar lavage (BAL) specimens. Remainders of
BAL fluids were obtained in conjunction with a prior
study of patients with COPD exacerbation [29, 30].
Mice. NE-deficient mice (NE−/−) were generated by
targeted mutagenesis [8]. NE−/− and wild type (WT)
mice (C57Bl/6 J, 8–10 weeks old) were housed in a
pathogen-free facility with 12 h light/dark cycle and pro-
vided with food and water ad libitum.
Cells. Human bronchial epithelial cell line 16HBE
(kindly provided by Dr. Gruenert, University of California
at San Francisco, San Francisco, CA) and mouse alveolar
cell line MLE15 (kindly provided by J. Wittset, University
of Cincinati, Cincinati, OH) were cultured to confluence
in DMEM (for 16HBE) or RPMI 1640 (for MLE15)
culture media as previously described [31, 32]. Prior to
any treatment, cells were washed three times with sterile
phosphate-buffered saline (PBS) and cultured for 1 h in
the absence of FCS.
Polymorphonuclear neutrophils (PMNs) were isolated
from mouse WT femur and tibia tips-derived bone mar-
row as previously described [33]. A Percoll gradient was
employed to separate morphologically mature neutro-
phils, which were used immediately. Purified neutrophils
represented >95 % of the cell population and >98 % were
viable as judged by differential counting and trypan blue
dye exclusion respectively.
Bacteria. In this work, we used Pseudomonas aerugi-
nosa H103 (kindly provided by R. Hancock, University
of British Columbia, Vancouver, Canada). Bacteria were
grown aerobically to late exponential phase (3 h),
washed twice, and resuspended in 1 ml of PBS (pH 7.4).
The optical density (OD) of bacterial culture was deter-
mined at 600 nm (OD) (OD 1 ≈ 109 bacteria/ml).
Exposure of epithelial cell protein extracts to NE
Media of cell cultures were removed and confluent cells
were scraped. Proteins were extracted from cell pellet
using RIPA buffer and quantified as previously described
[34]. Next, equal protein aliquots (10 μg) were incubated
alone or in the presence of varying concentrations of
NE, CG or PR3 at 37 °C for designated periods of time.
The reactions were carried out in a 20 μl volume in PBS
at pH 7.4, which should approximate the pH in the
extracellular milieu of the lung and corresponds to pH
optimum of NE. In parallel experiments, NE (50 nM,
highest concentration) was preincubated with SLPI
(100 nM) at 37 °C for 5 min prior to addition to cell
protein extracts.
Exposure of epithelial cells to NE
Confluent 16HBE epithelial cell monolayers were cul-
tured alone or in the presence of designated concentra-
tion of purified NE for a defined period of time [35]. In
parallel, NE was preincubated with SLPI at 37 °C for
5 min prior to addition to cells. At the end of treatment
time, culture supernatants were collected, centrifuged to
remove cell debris, and acetone-concentrated. Cells were
scraped and proteins were extracted and quantified as
described above. Equal aliquots of culture supernatants
or lysate proteins (10 μg) were resuspended in PBS, and
subjected to SDS-PAGE and Western blotting as
described below.
Immunofluorescence microscopy
MLE-15 epithelial cells were grown on cover slips to
confluence. Next, cell monolayers were cultured alone
or in the presence of designated concentration of puri-
fied NE for a defined period of time. In parallel experi-
ments, mouse PMNs were added to MLE-15 epithelial
cells at a ratio 1:10 (epithelial cell:PMN). Prior to
addition to epithelial cells, neutrophils were first primed
and stimulated by addition of LPS (10 μg/ml) and
formyl-methionyl-leucyl-phenylalanine (fMLP, 1 μM)
[34]. NE release from activated cells was examined using
NE specific chromogenic peptide substrate. Under these
experimental conditions, over 80 % of neutrophils were
still alive upon addition to epithelial cells, as judged by
trypan blue dye exclusion. However, their viability was
compromised 6 h after co-culture since we could barely
detect their nuclei by staining with TO-PRO-3 iodide.
Six hours post-treatment, cover slips were processed
for immunofluorescence microscopy. Briefly, cells were
fixed for 10 min in 3 % (w/v) paraformaldehyde.
Nonspecific binding was blocked with 3 % bovine serum
albumin in PBS for 30 min, and cells were incubated
with polyclonal antibody specific for mouse extracellular
E-cadherin domain (dilution 1:750) for 1 h at room
temperature. After washing, samples were FITC-labelled
secondary antibody-immunostained (dilution 1:2000) for
fluorescence microscopy [34]. The nuclei were stained
with TO-PRO-3 iodide (Molecular Probes) for 10 min.
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Following a final gentle wash, cells were mounted in
Vectashield (Vector Laboratories) on slides using Secure
Seal imaging spacers (Sigma). Samples were examined
using a LSM 510 Meta laser scanner microscope (Carl
Zeiss Inc., Thornwood, New York, USA). Equivalent
concentrations of preimmune serum were used as a
negative control. Fluorescence intensity was estimated
by determination of the average area of stained regions
[35, 36]. Briefly, 15 randomly digitized images represen-
tative of each condition of the experiments were cap-
tured in a blinded manner (A.B.) and analysed using the
image analysis software ImageJ (NIH, Bethesda, MD).
Time-lapse videomicroscopy
First, confluent monolayers of 16HBE epithelial cells
were first subjected to immunofluorescence staining as
described above. Cells were incubated with human anti-
E-Cad specific antibody against the extracellular domain
(dilution 1:750) followed by FITC-labelled secondary
antibody (dilution 1:2000). Next, cell monolayers were
incubated alone or in the presence of NE (200 nM). In
parallel experiments, cells were exposed to NE that was
pretreated with SLPI (400 nM) or SLPI alone.
Cell culture plates were transferred immediately to
Zeiss IM35 inverted microscope (Zeiss, Oberkochen,
Germany) equipped with an incubation chamber main-
tained at 37 °C with 5 % CO2 in a wet atmosphere.
Video recording was performed using a Panasonic
WVCD51 digital camera (Osaka, Japan) controlled by a
Sparc 2 Sun workstation (Sun Microsystems, Mountain
View, CA) with a video board (Parallax Graphics, Santa
Clara, CA) [31]. Images of untreated or NE-treated cells
were captured every 15 min for 6 h using 10X magnifi-
cation to analyse at least 100 cells per field of view.
Mouse model of pneumonia
Mice were intranasally challenged with P. aeruginosa
bacteria or sterile saline. Briefly, mice were anesthetized
followed by intranasal administration of 50 μl of sterile
PBS or containing a sublethal dose of bacteria (4×106
colony forming units (CFUs)/per mouse, which we have
previously shown to injure acutely mouse lungs [34].
Groups of mice (n = 4/genotype/time point) were
sacrificed at designated time points, and their lungs were
lavaged in situ using Hank’s balanced salt solution
(pH 7.4), cycled in three times. Identical recoveries of
lavages (700 ml/mouse) were obtained for each of the
experimental groups. Cell counts from BAL fluids were
immediately performed by hemocytometer and aliquots
of BAL fluids were cytospun and Wright-stained for
differential counting (Thermo Shandon and Fisher
Scientific). Next, the remaining BAL samples were cen-
trifuged for 10 min at 4 °C to remove cells, aliquoted
and snap-frozen until use. Mouse lungs were processed
for histologic analyses as previously described [35].
Western blotting
Equal proteins aliquots derived from cell cultures and
murine or human BAL fluids were resolved on 12 %
SDS-polyacrylamide gels and transferred to polyvinyli-
dene difluoride membranes (Millipore Corp., Bedford,
MA). Of note, unlike murine BAL fluids, human BAL
(5 ml) were concentrated by lyophilisation prior to
determination of protein concentration [35]. Blots were
incubated with the indicated antisera specific to extracel-
lular or cytoplasmic E-cad domains or NE (dilution for
E-cad antibodies 1:1000 and dilution for NE 1:2500)
[35]. Membranes were subsequently incubated with an
appropriate dilution of HRP-linked secondary IgG
(dilution 1:2000) in blocking buffer. Immunoreactive
fragments were visualized by enhanced chemilumines-
cence (ECL, Amersham Biosciences). Labelled pro-
teins or fragments were detected with the Molecular
Imager ChemiDoc XRS System and quantified using
Quantity One 1-D Analysis Software (Biorad, Marnes-
la-Coquette, France).
Neutrophil elastase activity
Neutrophil elastase activity in cell-free BAL fluids was
assessed using conventional chromogenic peptide
assays [35]. Briefly, BAL aliquots (100 μl) were incu-
bated with NE peptide substrate Meo-Suc-Al-Al-Pro-
Val-pNA (0.2 mM) for 60 min at 37 °C in a total
volume of 200 μl Tris-NaCl buffer (0.1 M Tris and
1 M NaCl, pH 7.4). The reactions were then spun (30 s,
12,000 rpm), and changes in the absorbance of the superna-
tants were determined spectrophotometrically at λ 410 nm.
Immunohistochemistry
Immunostaining on lung tissue sections was performed
as previously described [34]. Sections were incubated
with antibodies specific for mouse E-cad (dilution,
1:750) at 4 °C overnight. Next, samples were incubated
for 20 min with biotinylated secondary antibody and
labelled with HRP-conjugated streptavidin. Immune
complexes were visualized using 3’3-diaminobenzidine
(DAB) (Biocare Medical) as substrates for HRP and
counterstained with Mayer’s hematoxylin. Slides were
examined using a LSM 510 Meta laser scanner
microscope.
Lactate dehydrogenase (LDH) activity assay
Changes in LDH activity were used as a marker for cyto-
toxicity and were assessed in cell-free BAL fluids by the
LDH kit following the manufacturer’s recommendations
(Sigma-Aldrich) [37]. LDH catalyses the oxidation of lac-
tate to pyruvate. This reaction is coupled with reduction
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of NAD to NADH, which is followed spectrophotomet-
rically at 340 nm. The LDH activity is proportional to
the rate of absorbance changes. Briefly, 100 μl of BAL
samples were added to 900 μl LD-L reagent and changes
in absorbance were recorded over 3 min.
Albumin concentration
The albumin level changes were examined using the
bromocresol green assay (BCG, Sigma-Aldrich), accord-
ing to the manufacturer’s recommendations [37]. Briefly,
100 μl of samples or standards were incubated with
900 μl of BCG substrate for 60 s at room temperature.
Changes in absorbance were recorded by spectropho-
tometer at 628 nm and were proportional to the albu-
min concentrations in the samples.
Statistics
Densitometric quantification of western blots was per-
formed with the AIDA software (Raytest, Staubenhardt,
Germany). Data were analysed by Kruskall-Wallis and
Mann–Whitney tests with the StatView software (SAS
Institute Inc., Cary, NC, USA).
Results
NE degrades E-cad in an enzyme dose- and incubation
time-dependent fashion
To determine whether E-cad potentially represents a
substrate for NE, we incubated cell protein extracts con-
taining E-cad with purified NE. We used protein extracts
derived from bronchial cell line 16HBE or alveolar
epithelial-like cell line MLE15. Various NE concentra-
tions can be encountered in vivo including very high
concentrations near sites of granule exocytosis [38].
Accordingly, we examined a wide range of NE concen-
trations (1, 5, 10, 25, and 50 nM) against a fixed cell pro-
tein extract for varying incubation times. As judged by
Western blotting using specific polyclonal antibodies
against human or mouse extracellular E-cad domain,
identical fragmentation was observed with both human
and mouse cell line protein extracts in a manner
dependent of NE dose and incubation time (Fig. 1a-c).
Progressive cleavage of E-cad started with enzyme con-
centration as low as 5 nM. Also, NE catalysed rapid and
complete cleavage of intact E-cad (100 % of E-cad was
completely degraded by 50 nM of NE within 15 min)
(Fig. 1c). Of interest, identical degradation patterns were
obtained when incubations were performed in PBS
(pH 7.4) or Tris-buffered saline (data not shown).
Significantly, E-cad degradation was prevented when NE
was preincubated with the specific serine protease
inhibitor SLPI indicating that the catalytic activity of the
enzyme is required to cleave E-cad (Fig. 1d). Of interest,
cleavage of E-cad was also observed in the presence of
the other two neutrophil serine-proteases CG and PR3,
but NE was by far the most potent degrading protease
(Additional file 1). In the subsequent experiments, we
focused on NE for further characterization of E-cad
cleavage.
NE degrades cell-associated E-Cad and generates a distinct
extracellular fragment
The ability of NE to degrade E-cad was next examined
in cell culture system. After exposure of cells to increas-
ing concentrations of NE for a fixed time period, both
cell lysates and condition media were analysed by
Western blotting. As shown in Fig. 2a-left panel, using
an antibody raised against human N-terminal part of E-
cad, levels of a distinct cleavage product of about 80 kDa
increased progressively in culture supernatants in func-
tion of NE concentration coinciding with the disappear-
ance of E-cad protein in cell lysates (Additional file 2).
Using an antibody raised against the C-terminal part of
E-cad, complete degradation of the protein in cell lysates
was achieved at 200 nM, four fold higher than that used
with protein extracts of Fig. 1 (Fig. 2b, left panel). Ana-
lysis of condition media with an antibody against the
N-terminal part confirmed loss of intact E-cad, which
paralleled the appearance of the distinct 80 kDa degrad-
ation fragment (Fig. 2c, left panel). As in Fig. 1, inhib-
ition of NE by SLPI, prevented cell-associated E-cad
degradation and SLPI alone had no effect (Fig. 2b and
c). All these data were further supported by densitomet-
ric analyses (Fig. 2a - c; right panels).
Alteration of epithelial cell monolayer following exposure
to purified NE or activated neutrophil-derived NE
Next, to examine the impact of NE-mediated degrad-
ation of E-cad on the integrity of epithelial cell mono-
layer, purified or activated neutrophil-derived NE (free
and/or cell-bound) were added to cultured cells.
Immunofluorescence staining of untreated cell mono-
layer with N-terminal E-cad antibody found strong im-
munoreactive E-cad surrounding cells, consistent with
its known membrane localization that confers cells with
tight adhesion (Fig. 3a). Incubation with purified NE
(200 nM), however, induced loss of E-cadherin immuno-
staining resulting in the appearance of patchy gaps
within the monolayer (Fig. 3b).
We then sought to determine whether secreted NE
by activated neutrophils mediates similar effects. The
number of neutrophils added per well was calculated
to yield concentrations of liberated NE approximately
comparable to that shown in Fig. 3b [34]. As for NE,
addition of activated neutrophils resulted in loss of
epithelial cell layer integrity suggesting the most likely
implication of this protease (Fig. 3c). Immunoblotting
experiments on protein extracts of cells or culture su-
pernatants found loss of intact E-cad and generation
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of cleaved product (data not shown); findings consist-
ent with those in Fig. 2.
Spatio-temporal dynamics of NE-mediated disruption of
epithelial cell monolayer
To follow changes in epithelial cell monolayer integrity in
association with NE-mediated degradation of E-cad, we
used time-lapse videomicroscopy approach. Cell behav-
iour was analysed first by phase-contrast image record-
ings. Initially, cells displayed a flat polygonal morphology
(Fig. 4a). Following addition of NE, the morphology of
cells changed and became rounded due to detachment of
cells from each other, in distinct areas (Fig. 4b and an
additional movie file shows this in more detail [see
Additional file 3: Movie S1]). At the end of recording time,
considerable number of cells was floating in culture
medium. Of note, there were areas of the cell monolayer
that were not affected by morphologic changes.
Using immunofluorescence staining combined with
time-lapse videomicroscopy, the pattern of E-cad in un-
treated cells was similar to that seen in Fig. 3a through-
out the recording time. Indeed, E-cad was uniformly
distributed around cohesive cells (Fig. 4c). In contrast,
cells exposed to NE exhibited a dramatic decrease of
fluorescence intensity over recording time, concomitant
with the appearance of rounded cells and marked inter-
cellular space enlargement (Fig. 4d and an additional
movie file shows this in more detail [see Additional file 4:
Movie S2]). There were less striking morphologic changes
and variations in fluorescence intensity in plate wells
treated with either NE that was preincubated with SLPI or
SLPI alone (Fig. 4e and f and additional movie files show
this in more detail [see Additional file 5: Movie S3 and
Additional file 6: Movie S4]).
In vivo detection of E-cad and NE
Next, we determined whether NE mediates E-cad
degradation in injured lungs using our previously
described mouse P. aeruginosa pneumonia model [34].
To circumvent the confounding effect of P. aeruginosa
metalloelatase, known to degrade a variety of host mole-
cules, we employed P. aeruginosa strain H103, which
lacks this enzyme [39]. Immunostaining of lung sections
from unchallenged control wild type mice found E-cad
Fig. 1 Degradation of E-cad is NE concentration and incubation time dependent. Epithelial cell protein extracts containing E-cadherin (10 μg)
were incubated alone or in the presence of varying concentrations of NE for various time periods. The reactions were resolved by SDS-PAGE
under reducing conditions and visualized by immunoblotting. a-b, incubation with NE (0, 1, 5, 10, 25, 50 nM) for defined time point (30 min)
resulted in an enzyme dose-dependent degradation of E-cad derived from 16HBE (a) or MLE15 (b) epithelial cell extracts. c, Incubation of MLE15
epithelial cell extracts with NE (50 nM) for defined time points (0, 10, 15, 20, 25, 30 min) resulted in stepwise degradation of E-cad. d, E-cad
cleavage was largely abrogated in both 16HBE and MLE15 protein extracts when NE (50 nM) was pre-incubated with the physiologic serine proteinase
inhibitor SLPI (100 nM). Molecular weight (MW) (kDa) standards are between panels. The findings are illustrative of at least three independent
experiments
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expression restricted to epithelia, consistent with the
known sites of E-cad localization (Fig. 5a) [25]. However,
O.N. post-infection with P. aeruginosa, strong E-cad im-
munostaining was observed in both epithelial lining and
intraalveolar exudates (Fig. 5b, upper panels). No stain-
ing was seen when the primary antibody was replaced
with the preimmune serum (Fig. 5b, lower panels). Next,
we analysed lung tissues of control and infected animals
to look for evidence of simultaneous presence of active
NE and E-cad. NE activity assay in BAL fluids detected
significant amounts of NE suggesting the presence of ac-
tive neutrophil-derived NE within the alveolar spaces
(Fig. 5c). Concomitant with E-cad degradation and active
NE, analysis of the inflammatory response in BAL fluids
found a massive cellular recruitment predominated with
neutrophils and increased albumin level and LDH
release (Additional file 7, [34, 40]).
NE contributes to degradation of endogenous E-cad in
the setting of lung injury
To assess the specific role of NE in neutrophil-
mediated degradation of E-cad, WT and NE-deficient
(NE−/−) mice were i.n. challenged with P. aeruginosa
as described above and sacrificed 4 and 24 h
Fig. 2 NE degrades cell-associated E-Cad and generates a distinct extracellular fragment. Confluent 16HBE cells were left untreated or treated with
varying concentrations of purified NE (0, 2, 20, or 200 nM) for 6 h. Next, equal protein aliquots from culture supernatants and cell lysates (10 μg)
were subjected to SDS-PAGE and immunoblotting using antibodies raised against N- and C-terminal parts of E-cad respectively. a, left panel.
Anti-E-cad N-terminal antibody revealed a progressive increase of a distinct N-terminal fragment of about 80 kDa that paralleled the increase of
NE concentration. a, lower panel, densitometric analysis confirms increased levels of E-cad fragment. Data are mean values ± SD. *p < 0.05;
Kruskall-Wallis test. b, right panel. Loss of intact E-cad was achieved with NE at 200 nM. Of note, anti-E-cad C-terminal antibody detected varying
fragments. NE inhibition with SLPI (400 nM) prevented degradation of cell-associated E-cad. b, lower panel, densitometric analysis found low
levels of intact E-cad when cells were exposed to NE alone. However, preincubation of NE with SLPI prevented considerably such degradation.
Data are mean values ± SD. *p < 0.05; Mann–Whitney test. c, left panel. Immunoblotting analysis of condition media from B with an anti-E-cad
N-terminal part confirmed the generation of the distinct 80 kDa degradation product, which paralleled the loss of intact E-cad. c, lower panel,
densitometric analysis found increased level of E-cad fragment concomitant with low levels of intact E-cad when cells were exposed to NE alone in B.
However, preincubation of NE with SLPI prevented considerably E-cad degradation. MW standards are on wright. a.u., arbitrary unit. Data are mean
values ± SD. * corresponds to p < 0.05 for cleaved versus intact E-cad; Mann–Whitney test. Experiments were repeated three times with similar findings
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post-challenge. As shown in Fig. 6a and b, immuno-
blotting of infected cell-free WT and NE−/− BAL
fluids and densitometric analysis revealed gradual
generation of endogenous cleavage product in func-
tion of time, with similar ~80 kDa size to that
generated by purified NE. More importantly, NE−/−
cell-free BAL fluids showed less degradation of E-cad
as compared to WT cell-free BALs. NE activity assay
analysis revealed the presence of active NE in WT,
but not NE−/−, cell-free BAL fluids that became
abundant at time point 24 h (Fig. 6c). Thus, our find-
ings demonstrate that NE contributes to efficient
cleavage of E-cad. Of note, low levels of E-cadherin
extracellular domain were also seen in PBS-challenged
mice. This suggests that either a basal level of
E-cadherin is constitutively shed from the epithelium
or as a consequence of the shear stress of the in and
out cycling of PBS during lung lavage.
Detection of both cleaved E-cad and NE in BAL of patients
with exacerbated COPD
To determine the relevance of cell and animal data to
human lung diseases, we looked for evidence for the pres-
ence of both degraded E-cad and NE in cell-free BAL
fluids obtained from exacerbated COPD patients charac-
terized by an abnormal influx of neutrophils. As shown in
Fig. 7a, there was a marked increase in the levels of
~80 kDa immunoreactive E-cad fragment in all cell-free
BAL samples, a finding that corroborated our cell culture
and mouse data. Next, after stripping and immunoblotting
of the same Western blot membranes for NE, densitomet-
ric analyses revealed the presence of increased NE levels
Fig. 3 Purified NE or activated neutrophils alters epithelial monolayer integrity. Confluent cultured MLE15 cells were exposed to purified or activated
neutrophils for 6 h. a, immunofluorescence staining of untreated cell monolayer with N-terminal E-cad antibody found strong immunoreactive E-cad
surrounding cells. b, exposure of cells to purified NE (200 nM) resulted in considerable loss of E-cadherin immunostaining and disruption of cell-cell
adhesion. c, activated neutrophils alter epithelial cell layer integrity with the appearance of patchy gaps. The number of neutrophils added to cells was
calculated to yield concentration of liberated NE closely equivalent to that of purified NE. d, fluorescence quantification of cultured cells. Note
NE-treated cells or cells co-cultured with neutrophils showed significantly less staining than untreated cells. Data are presented as means ± SEM per
experimental condition. **** correspond to p < 0.0001 for conditions of cell treatment with NE or PMNs versus control. a.u., arbitrary unit. Scale bar,
120 μm. Experiments were repeated three times with similar observations
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as well confirming the predominance of active neutrophils
in the samples (Fig. 7b). Detection of both cleaved E-cad
and NE suggests, thus, that both proteins are present in
inflamed human lungs and support the hypothesis that
NE could target E-cad in vivo contributing potentially to
the setting of lung inflammation and injury.
Discussion
That E-cad is susceptible to NE has been previously re-
ported in limited cell culture [27, 41, 42] and experimen-
tal model studies [24–26]. The originality of our work is
several folds. As expected, the inflammatory response of
our mouse model of acute Pseudomonas pneumonia was
characterized by increased alveolocapillary permeability,
neutrophil influx, and LDH. Using genetically engi-
neered mice deficient in NE in this experimental model,
we provide compelling evidence that NE contributes
substantially to E-cad degradation in injured lungs.
Videomicroscopy approach showed that the spatial and
temporal NE-mediated degradation of E-cad was accom-
panied with the abrogation of this latter’s cell-cell adhe-
sion function. More importantly, the presence of both
Fig. 4 Spatio-temporal changes of epithelial cell monolayer following treatment with NE. Confluent monolayers of 16HBE epithelial cells were
incubated alone or in the presence of defined NE concentration (200 nM). Briefly, cells were first subjected to immunofluorescence staining of
E-cad as described in material and methods. Next, cell monolayers were left untreated or exposed to NE (200 nM) alone or pre-incubated with
SLPI (400 nM). Video recording was performed for 6 h. a-b, Representative phase contrast images of untreated (a) or NE-exposed (b) 16HBE cells.
Unlike control cells with flat polygonal morphology, NE-treated cells detached from each other and displayed rounded morphology. c-d,
Representative immunofluorescence images of untreated or NE-exposed 16HBE cells. Immunofluorescent staining showed E-cad surrounding
uniformly cohesive cells (c). In contrast, cells exposed to NE lost their immunostaining for E-cad coinciding with the appearance of intercellular
gaps (d). Of note, NE preincubated with SLPI (e) or SLPI alone (f) had less striking effect on E-cad distribution and monolayer integrity. Asterisks
depict formed gaps. Scale bar = 40 μm. Experiments were repeated twice with similar observations
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degraded E-cad and NE was detected in COPD exacerba-
tion, a clinical manifestation characterized by predomin-
ant neutrophilic inflammatory response. It must be noted
that a limited number of human samples (n = 5) have been
examined in this study and to further document the gen-
erality of our findings investigation of a large number of
human BAL fluids is warranted. Altogether, these data
suggest the likelihood contribution of NE-mediated deg-
radation of E-cad in the development of inflammation and
tissue destruction in the setting of neutrophil-rich lung
diseases. Of importance, the concentrations of NE used in
both in vitro and cell culture studies are relevant since
they can be even exceeded in pulmonary diseases [43, 44].
Also, in the mouse experimental model, E-cad degradation
was not completely prevented in the absence of NE sug-
gesting contribution of other proteases. In this regard, ac-
tivated PMNs release two other members of neutrophil
serine protease family, cathepsin G (CG) and proteinase 3
(PR3) known to share the same conserved catalytic cleft
as NE [5]. Interestingly, our in vitro data showed that
Fig. 5 In vivo detection of E-cad and NE. a, Lung tissue sections from saline control mice were immunostained for mouse E-cad. Under physiologic
conditions, E-cad is restricted to epithelial lining (arrowheads), consistent with the known localization of E-cad expression. b, Representative mouse
lung tissue section following O.N. challenge with P. aeruginosa. b, upper panels, Immunostaining for E-cad detected the antigen within inflamed
airspaces and in close spatial contact with the cellular infiltrates (arrows). b, lower panels, absence of E-cad staining in the presence of preimmune
serum. c, absence of staining was seen when the primary antibody was replaced with the preimmune serum. c, Enzymatic activity assay detected free
active NE in cell-free BAL. Consistent with the neutrophilic response to P. aeruginosa, increasing levels of active NE were detected in cell-free BAL fluids
following O.N. infection (infected tissues). No NE activity was detected in mice challenged with sterile saline (PBS). Purified active NE (100 ng) was used
as control. Data were consistent in all challenged mice (bars ± SEM; *** and **** correspond to p < 0.001 and p < 0.000 respectively for infection versus
PBS). O.N. corresponds to 24 h. Scale bar of left images, 150 μm. Scale bar of right images, 45 μm
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Fig. 6 In vivo contribution of NE to degradation of endogenous
E-cad. a, Representative image of equal BAL fluid protein aliquots (in
20 μl) from control mice and mice i.n. challenged with P. aeruginosa
for 4 h or O.N. that were reduced and processed for immunoblotting
using E-cad N-terminal antibody. Both 4 and O.N. time points revealed
a gradual degradation of endogenous E-cad with generation of a
distinct ~80 kDa cleavage fragment that migrated similar to the cleavage
fragment generated by purified NE. Note cell-free NE−/− BAL fluids
showed less cleaved E-cad fragment by comparison to cell-free WT BALs.
b, Densitometric analysis of immunoblot images corresponding to all
cell-free BAL fluids per group, genotype and condition confirmed the
protein profile of Fig. a. c, enzymatic activity assay analysis revealed the
presence of active NE in cell-free WT, but not NE−/−, BAL fluids that
became abundant over time (O.N.). Data were similar in all challenged mice
and mouse experiment was repeated once with reproducible findings
(bars ± SEM; **** corresponds to p<0.0001for infection versus PBS)
Fig. 7 Detection of cleaved endogenous E-cad coincides with NE in
human diseased lungs. Equal protein aliquots (in 20 μl) of concentrated
cell-free BAL derived from patient with COPD exacerbation (n = 5) were
subjected to SDS-PAGE and immunoblotting using antibodies raised
against human E-cad extracellular domain and NE respectively. a,
densitometric analysis found increased level of immunoreactive E-cad
fragment (~80 kDa). b, densitometric analysis revealed the presence of
immunoreactive NE in the same samples of (a). Experiments were
repeated three times with similar results (bars ± SEM; **** corresponds
to p < 0.0001 for COPD exacerbation versus control)
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while the two other members of neutrophil serine prote-
ase family, cathepsin G (CG) and proteinase 3 (PR3) de-
graded E-cad, NE was the most potent degrading enzyme.
The relative importance of CG and PR3 in cleaving E-cad
would be, however, best defined using mice deficient in
these proteases.
In general, epithelial cell-cell adhesion proteins are
grouped in three categories (from apical to basal
side): tight junctions (e.g., ZO-1 and occludin), adhe-
rens junctions (E-cad) and desmosomes. There is a
large body of evidence indicating that E-cad repre-
sents a key protein for the establishment and main-
tenance of cohesive epithelium. Indeed, the protein
mechanically ensures tight adhesion of cells [45]. It is
required for the formation of other junctional com-
plexes such as tight junctions [46]. E-cad regulates
cell proliferation and differentiation [47]. Furthermore,
E-cad plays a modulatory role in host immune re-
sponses by regulating the expression of growth factors
and proinflammatory mediators [48]. Consequently,
there are important functional implications of E-cad
degradation. Though we have no direct in vivo evi-
dence that degradation of E-cad by NE leads to lung
epithelial disruption and injury, our findings still sug-
gest strongly that this protease contributes to this
physiopathologic phenotype. Because the N-terminal
region corresponds to E-cad homophilic interaction
hence cell-cell adhesion, its cleavage by NE (see
below) is likely to disrupt and/or destabilize the epi-
thelium integrity. This is consistent with our findings
of epithelial monolayer disruption following its expos-
ure to NE. It also implies that in the setting of lung
injury, NE-mediated E-cad degradation likely partici-
pates to epithelial barrier alteration contributing to in-
creased alveolocapillary membrane permeability and
exudate within airspaces. While our in vivo finding with
NE−/− mice show that NE deficiency was associated with
considerable decrease of E-cad degradation, lung inflam-
mation and injury of these mice was, however, similar to
that seen in WT mice including inflammatory cell influx
and albumin levels. Among the explanations could be that
other proteases (e.g., CG and PR3) cleave E-cad masking
therefore the relative contribution of NE. Some matrix
metalloproteases (MMP) including MMP-7 cleave also
E-cad [49, 50]. Although unlikely, the possibility that NE
cleavage of E-cad corresponds to an epiphenomenon is
plausible as well.
NE cleavage of E-cad was marked by the generation
of a distinct fragment (about 80 kDa) in both cell
culture system and in vivo. In their mouse model
challenged with human NE, Evans SM and his
colleagues reported the release into BAL fluids of a
cleavage product with similar size and suggested NE
as the prime protease targeting E-cad [25]. Given the
estimated size of E-cad fragment detected by Western
blotting and the epitope (amino acid sequence
Asp157-Val709) that was used to raise anti-E-cad N-
terminus antibody, we readily inferred that NE cleaves
E-cad within its extracellular region. Furthermore, in-
spection of the primary structure of E-cad especially
within the N-terminal domain (amino acid sequence
ranging from 24 to 713, NCBI accession: Q9R0T4)
revealed the presence of peptide bonds that are pre-
ferred by NE. Finally, Mayerle J. et al. identified a
cleavage site for NE within EC-3 domain of E-cad
extracellular portion (starting amino acid at position
394) [24]. Whether this cleaved fragment possesses
in vivo biologic functions in inflamed lungs remains
to be assessed. Interestingly, analysis of our immuno-
stained lung tissue sections of infected mice suggested
that E-cad fragments were engulfed by recruited neu-
trophils (left panel of Fig. 5b); an observation that
confirms previously reported findings by Evans SM
et al. [25]. It has been, however, shown in cell culture
studies that cleaved E-cad fragment induces expres-
sion and activation of proteases such as matrix metal-
loproteases [51] suggesting that a hypothetical vicious
cycle might exist between proteases and structural
proteins (e.g., E-cad in this study), which perpetuates
tissue inflammation and injury. Other studies reported
that this E-cad fragment exhibits a stimulatory effect
on the migratory capability of cells [52].
A common denominator of neutrophil-rich lung inflam-
matory diseases (e.g., ALI/ARDS, CF, non-CF bronchiec-
tasis) is epithelial injury. Thus, cleavage of E-cad by
neutrophil-derived NE, whose level and activity are known
to be increased, could be anticipated. Such proteolytic
event could occur during the migration of PMNs across
the epithelium and/or their accumulation in the vicinity of
epithelial lining. In this regard and as mentioned earlier,
NE could degrade first other cell-cell junction proteins be-
fore E-cad (unpublished data, [27]. Also, the detected
E-cad fragment in our mouse and human studies could in-
clude products derived from degraded VE-cad [28]; a
hypothesis that warrants investigation. Other scenarios of
NE involvement in E-cad degradation and ensued epithe-
lium disruption could be envisioned. Recently, we
reported that NE activates calpain, which is known to
cleave E-cad [53, 54]. As mentioned above, tight junction
and adherens junction proteins are spatially and function-
ally linked in epithelia. Degradation of E-cad could there-
fore lead to dysfunctionning of tight junctions and thus
enhanced disruption of the epithelium [55].
It must be emphasized that in this study, we focused
on the time point 24 h post-infection because it corre-
sponds to a sharp increase of neutrophil numbers and
enhanced NE activity by comparison to the other time
points [37]. But, E-cad degradation could be seen at any
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time as long as significant amounts of free active NE are
available and the microenvironment allows interaction
of the enzyme and its target. As mentioned above, other
proteases namely MMP have been reported to cleave
E-cad [49, 50]. For example, McGuire JK et al. reported
that MMP-7 mediates E-cadherin ectodomain shedding
in injured lung epithelium [49, 50]. Interestingly, this
group proposed that shedding of E-cad is required for
epithelial repair. Altogether, previously reported findings
along with this work point to E-cad cleavage as “double-
edged sword” process and raise a relevant question of
whether such cleavage contributes to dysfunctional or
normal repair of injured epithelium. Our cell-free and
cell culture data show that degradation of E-cad was
blocked by NE physiological inhibitor, SLPI. As such,
in vivo E-cad cleavage and associated phenotype (i.e., in-
jury or repair) are in any case contingent on the equilib-
rium of active protease(s) (NE in this study) and their
corresponding endogenous inhibitors within lung
microenvironment.
Conclusion
In conclusion, we provide in this study compelling
evidence that NE contributes substantially to E-cad deg-
radation in inflamed lung situations. However, based on
our in vivo studies with mice deficient in NE, it seems
that inhibition of this protease alone may not prevent
proteolysis-mediated inflammation and tissue degrad-
ation seen in neutrophil-rich pathologies.
Additional files
Additional file 1: Degradation of E-cad by NE, PR3 and CG. MLE15 cell
protein extracts containing E-cadherin (10 μg) were incubated for 30 min
alone (Ctrl) or in the presence of 25 nM of purified NE, PR3, and CG. The
reactions were resolved by SDS-PAGE under reducing conditions and
visualized by immunoblotting as in Fig. 1. Note that NE is the most potent
protease to cleave E-cad followed by PR3 and CG. Molecular weight (kDa)
standards are on the right. The findings are illustrative of at least three
independent experiments. (TIFF 2703 kb)
Additional file 2: NE degrades cell-associated E-Cad. Confluent 16HBE cells
were left untreated or treated with varying concentrations of purified NE (0, 2,
20, or 200 nM) for 6 h. Next, equal protein aliquots from cell lysates (10 μg)
were subjected to SDS-PAGE and immunoblotting using antibodies raised
against C-terminal parts of E-cad. A, Left panel. Anti-E-cad C-terminal antibody
revealed a progressive decrease of E-cad that paralleled the increase of NE
concentration. Right panel, densitometric analysis confirms decreased levels of
E-cad. Data are mean values ± SD. *p< 0.05; Kruskall-Wallis test. Of note,
anti-E-cad C-terminal antibody detected varying fragments. Immunoblotting
for GAPDH, an internal control, was used as protein loading control of cell
lysate proteins. Experiments were repeated three times. (TIFF 2703 kb)
Additional file 3: Videomicroscopy 1 (Bright field, addition of NE to
cultured cells). (MOV 2864 kb)
Additional file 4: Videomicroscopy 2, (Immunofluorescence, addition of
NE to cultured cells). (MOV 1338 kb)
Additional file 5: Videomicroscopy 3, (Immunofluorescence,
preincubation of NE with SLPI prior to addition to cultured cells). (MOV 2194 kb)
Additional file 6: Videomicroscopy 4, (Immunofluorescence, addition of SLPI
alone to cultured cells). (MOV 2084 kb)
Additional file 7: Cell influx, albumin levels, and LDH release in BAL fluids of
NE−/− and WT mice in response to P. aeruginosa infection 24 h post-challenge.
A. Total leukocyte counts in BAL fluids from NE−/− and WT mice
(n = 4/genotype) following i.n. challenge with a sub-lethal dose of
P. aeruginosa. B. Representative cytospin micrographs of BAL fluids
from both WT and NE−/− mice. Left panel, insignificant cell numbers
corresponding mostly to resident alveolar macrophages, were detected in BAL
fluids from saline control mice. Right panel, predominance of neutrophils.
Scale bar, 50 μm. C. Albumin levels in cell-free BAL fluids from mice in A. D.
LDH release in cell-free BAL fluids from mice in A. Data are mean values ± SD.
*p< 0.05; differences between genotypes of mice were tested by two-way
analyses of variances with group and time as factors. (TIFF 2703 kb)
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